Corvus Pharmaceuticals
CRVS
#8137
Rank
S$0.26 B
Marketcap
$3.84
Share price
-4.68%
Change (1 day)
62.59%
Change (1 year)

EPS for Corvus Pharmaceuticals (CRVS)

EPS in 2023 (TTM): -$1.16

According to Corvus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.13. In 2022 the company made an earnings per share (EPS) of -$1.20 an increase over its 2021 EPS that were of -$1.43.

EPS history for Corvus Pharmaceuticals from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.16-3.55%
2022-$1.20-16.04%
2021-$1.43404.76%
2020-$0.28-86.79%
2019-$2.14-9.14%
2018-$2.35-35.66%
2017-$3.66-60.47%
2016-$9.26348.05%
2015-$2.07

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.93 159.52%๐Ÿ‡บ๐Ÿ‡ธ USA